211 related articles for article (PubMed ID: 11937594)
1. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.
Mankoff DA; Dunnwald LK; Gralow JR; Ellis GK; Charlop A; Lawton TJ; Schubert EK; Tseng J; Livingston RB
J Nucl Med; 2002 Apr; 43(4):500-9. PubMed ID: 11937594
[TBL] [Abstract][Full Text] [Related]
2. Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.
Mankoff DA; Dunnwald LK; Gralow JR; Ellis GK; Schubert EK; Tseng J; Lawton TJ; Linden HM; Livingston RB
J Nucl Med; 2003 Nov; 44(11):1806-14. PubMed ID: 14602864
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy.
Tseng J; Dunnwald LK; Schubert EK; Link JM; Minoshima S; Muzi M; Mankoff DA
J Nucl Med; 2004 Nov; 45(11):1829-37. PubMed ID: 15534051
[TBL] [Abstract][Full Text] [Related]
4. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
Doot RK; Dunnwald LK; Schubert EK; Muzi M; Peterson LM; Kinahan PE; Kurland BF; Mankoff DA
J Nucl Med; 2007 Jun; 48(6):920-5. PubMed ID: 17504870
[TBL] [Abstract][Full Text] [Related]
5. Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.
Dunnwald LK; Gralow JR; Ellis GK; Livingston RB; Linden HM; Specht JM; Doot RK; Lawton TJ; Barlow WE; Kurland BF; Schubert EK; Mankoff DA
J Clin Oncol; 2008 Sep; 26(27):4449-57. PubMed ID: 18626006
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.
Humbert O; Riedinger JM; Vrigneaud JM; Kanoun S; Dygai-Cochet I; Berriolo-Riedinger A; Toubeau M; Depardon E; Lassere M; Tisserand S; Fumoleau P; Brunotte F; Cochet A
J Nucl Med; 2016 Nov; 57(11):1707-1712. PubMed ID: 27103025
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors.
Cochet A; Pigeonnat S; Khoury B; Vrigneaud JM; Touzery C; Berriolo-Riedinger A; Dygai-Cochet I; Toubeau M; Humbert O; Coudert B; Fumoleau P; Arnould L; Brunotte F
J Nucl Med; 2012 Apr; 53(4):512-20. PubMed ID: 22343501
[TBL] [Abstract][Full Text] [Related]
9. PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.
Dunnwald LK; Doot RK; Specht JM; Gralow JR; Ellis GK; Livingston RB; Linden HM; Gadi VK; Kurland BF; Schubert EK; Muzi M; Mankoff DA
Clin Cancer Res; 2011 Apr; 17(8):2400-9. PubMed ID: 21364034
[TBL] [Abstract][Full Text] [Related]
10. Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.
Dunnwald LK; Gralow JR; Ellis GK; Livingston RB; Linden HM; Lawton TJ; Barlow WE; Schubert EK; Mankoff DA
Cancer; 2005 Feb; 103(4):680-8. PubMed ID: 15637688
[TBL] [Abstract][Full Text] [Related]
11. Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.
Partridge SC; Vanantwerp RK; Doot RK; Chai X; Kurland BF; Eby PR; Specht JM; Dunnwald LK; Schubert EK; Lehman CD; Mankoff DA
J Magn Reson Imaging; 2010 Nov; 32(5):1124-31. PubMed ID: 21031518
[TBL] [Abstract][Full Text] [Related]
12. Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer.
Specht JM; Kurland BF; Montgomery SK; Dunnwald LK; Doot RK; Gralow JR; Ellis GK; Linden HM; Livingston RB; Allison KH; Schubert EK; Mankoff DA
Clin Cancer Res; 2010 May; 16(10):2803-10. PubMed ID: 20460489
[TBL] [Abstract][Full Text] [Related]
13. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Blood Flow and Metabolism on Dual-Acquisition
Humbert O; Lasserre M; Bertaut A; Fumoleau P; Coutant C; Brunotte F; Cochet A
J Nucl Med; 2018 Jul; 59(7):1035-1041. PubMed ID: 29439010
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.
Eby PR; Partridge SC; White SW; Doot RK; Dunnwald LK; Schubert EK; Kurland BF; Lehman CD; Mankoff DA
Acad Radiol; 2008 Oct; 15(10):1246-54. PubMed ID: 18790395
[TBL] [Abstract][Full Text] [Related]
16. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Radiomics for Pretreatment
Ha S; Park S; Bang JI; Kim EK; Lee HY
Sci Rep; 2017 May; 7(1):1556. PubMed ID: 28484211
[TBL] [Abstract][Full Text] [Related]
18. [Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer].
Li D; Chen JH; Wang J; Ling R; Yao Q; Wang L
Ai Zheng; 2007 Aug; 26(8):900-4. PubMed ID: 17697556
[TBL] [Abstract][Full Text] [Related]
19. 2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Link JM; Lewellen TK; Lewellen B; Freeman SD; Mankoff DA; Eary JF; Krohn KA
Clin Cancer Res; 2002 Apr; 8(4):971-9. PubMed ID: 11948102
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer.
Champion L; Lerebours F; Alberini JL; Fourme E; Gontier E; Bertrand F; Wartski M
J Nucl Med; 2015 Sep; 56(9):1315-21. PubMed ID: 26159587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
